Cytora Ltd.

Industry · 2 registered clinical trials.

Status	Trial	Phase	Started
Active Not Recruiting	Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Multiple System Atrophy, MSA - Multiple System Atrophy	Phase 1	2022-11-07
Unknown	Study for Treatment of Chronic Diabetic Foot Ulcers With the Investigational Allogeneic Cell Therapy Product, Diabetic Foot, Diabetic Foot Ulcer, Diabetic Foot Ulcer Neuropathic	Phase 1	2022-01-06